XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
REVENUE        
Sales $ 1,004 $ 44,276 $ 2,022 $ 123,956
Cost of goods sold 1,005 23,134 1,739 88,933
Gross profit (loss) (1) 21,142 283 35,023
OPERATING EXPENSES        
General and administrative expenses $0, $4,097, $0, and $381,471 in stock-based compensation, respectively 5,039,036 4,419,545 9,387,310 7,783,293
Research and development $0, $1,000,000, $10,000 and $6,712,663 in stock-based compensation, respectively 764,327 1,553,360 1,973,532 9,698,626
Sales and marketing $473,311, $0, $473,311, and $0 in stock-based compensation, respectively 349,031 24,218 399,951 64,731
Total operating expenses 6,152,394 5,997,123 11,760,793 17,546,650
NET LOSS FROM OPERATIONS (6,152,395) (5,975,981) (11,760,510) (17,511,627)
OTHER INCOME (EXPENSE)        
Interest expense (47,352) (1,091,568) (204,851) (3,580,613)
Interest income 78,566 378 78,854 755
Amortization of debt discount (1,212,246) (556,708) (1,412,530) (1,192,418)
Gain (loss) on note exchange agreement (208,670)
Change in fair value of derivative liability 980 14,125
Change in fair value of Evofem warrants (63,211) (63,211)
Total other expense (1,243,263) (1,647,898) (1,587,613) (4,980,946)
Net loss before income taxes (7,395,658) (7,623,879) (13,348,123) (22,492,573)
Income tax provision
NET LOSS (7,395,658) (7,623,879) (13,348,123) (22,492,573)
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (138,850) (74,260) (381,006) (213,227)
NET LOSS ATTRIBUTABLE TO ADITXT, INC. & SUBSIDIARIES $ (7,256,808) $ (7,549,619) $ (12,967,117) $ (22,279,346)
Net loss per share, basic (in Dollars per share) $ (3.45) $ (1,047.17) $ (9.22) $ (3,262.64)
Net loss per share - diluted (in Dollars per share) $ (3.45) $ (1,047.17) $ (9.22) $ (3,262.64)
Weighted average number of shares outstanding during the period, basic (in Shares) 2,101,701 7,210 1,406,545 6,829
Weighted average number of shares outstanding during the period - diluted (in Shares) 2,101,701 7,210 1,406,545 6,829